The UCSF-Stanford Center of Excellence in Regulatory Science and Innovation (UCSF-Stanford CERSI) is pleased to present the fifth annual Innovations in Regulatory Science Summit, a gathering of leaders in the academia, industry, and regulatory sectors to discuss the role of regulatory science in medical product development. 

The 2024 CERSI Innovations in Regulatory Science Summit will have a major focus on emerging issues in regulatory science including medical misinformation and its impact on public health, manufacturing and supply chain of medical products, and yet another exciting panel featuring former FDA Commissioners on the latest issues facing the Agency. New this year will also be debates on exciting topics in regulatory science.

The goal of the summit is to stimulate discussion across sectors and to critically consider lessons learned and scientific issues that need addressing to expeditiously and safely advance the development, approval, and monitoring of medical products.